4//SEC Filing
MORNEAU MICHAEL 4
Accession 0001209191-20-050734
CIK 0001607678other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:21 PM ET
Size
6.9 KB
Accession
0001209191-20-050734
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2020-09-15$6.25/sh−1,557$9,731→ 97,873 total - Award
Common Stock
2020-09-15+4,500→ 99,430 total
Footnotes (3)
- [F1]The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2020, 33.33% of which vested on September 15, 2020 upon the achievement of a non-financial performance goal.
- [F2]Includes 2,090 shares acquired on May 20, 2020 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
- [F3]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to a performance restricted stock unit award.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001517780
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 5:21 PM ET
- Size
- 6.9 KB